Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 75060* | 2014 |
Clinical guidelines for the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report National Institutes of Health Obes res 6 (2), 51S-209S, 1998 | 9327* | 1998 |
2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on … MD Jensen, DH Ryan, CM Apovian, JD Ard, AG Comuzzie, KA Donato, ... Circulation 129 (25_suppl_2), S102-S138, 2014 | 5808 | 2014 |
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and … P Poirier, TD Giles, GA Bray, Y Hong, JS Stern, FX Pi-Sunyer, RH Eckel Circulation 113 (6), 898-918, 2006 | 4868 | 2006 |
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study Diabetes Prevention Program Research Group The Lancet 374 (9702), 1677-1686, 2009 | 3672 | 2009 |
Medical hazards of obesity FX Pi-Sunyer Annals of internal medicine 119 (7_Part_2), 655-660, 1993 | 2167 | 1993 |
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial FX Pi-Sunyer, LJ Aronne, HM Heshmati, J Devin, J Rosenstock, ... Jama 295 (7), 761-775, 2006 | 1628 | 2006 |
The obesity epidemic: pathophysiology and consequences of obesity FX Pi‐Sunyer Obesity research 10 (S12), 97S-104S, 2002 | 1322 | 2002 |
Association of an intensive lifestyle intervention with remission of type 2 diabetes EW Gregg, H Chen, LE Wagenknecht, JM Clark, LM Delahanty, J Bantle, ... Jama 308 (23), 2489-2496, 2012 | 859 | 2012 |
Health implications of obesity FX Pi-Sunyer The American journal of clinical nutrition 53 (6), 1595S-1603S, 1991 | 851 | 1991 |
Comparisons of waist circumferences measured at 4 sites J Wang, JC Thornton, S Bari, B Williamson, D Gallagher, SB Heymsfield, ... The American journal of clinical nutrition 77 (2), 379-384, 2003 | 830 | 2003 |
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ... The Lancet 389 (10077), 1399-1409, 2017 | 797 | 2017 |
Obstructive sleep apnea among obese patients with type 2 diabetes GD Foster, MH Sanders, R Millman, G Zammit, KE Borradaile, ... Diabetes care 32 (6), 1017-1019, 2009 | 766 | 2009 |
Dietary carbohydrate (amount and type) in the prevention and management of diabetes: a statement by the American Diabetes Association NF Sheard, NG Clark, JC Brand-Miller, MJ Franz, FX Pi-Sunyer, ... Diabetes care 27 (9), 2266-2271, 2004 | 756 | 2004 |
C-terminal octapeptide of cholecystokinin decreases food intake in man HR Kissileff, FX Pi-Sunyer, J Thornton, GP Smith The American journal of clinical nutrition 34 (2), 154-160, 1981 | 739 | 1981 |
Weight loss with self-help compared with a structured commercial program: a randomized trial S Heshka, JW Anderson, RL Atkinson, FL Greenway, JO Hill, SD Phinney, ... Jama 289 (14), 1792-1798, 2003 | 667 | 2003 |
Weight stability masks sarcopenia in elderly men and women D Gallagher, E Ruts, M Visser, S Heshka, RN Baumgartner, J Wang, ... American Journal of Physiology-Endocrinology and Metabolism 279 (2), E366-E375, 2000 | 655 | 2000 |
A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study GD Foster, KE Borradaile, MH Sanders, R Millman, G Zammit, ... Archives of internal medicine 169 (17), 1619-1626, 2009 | 617 | 2009 |
Glycemic index and disease FX Pi-Sunyer The American journal of clinical nutrition 76 (1), 290S-298S, 2002 | 614 | 2002 |
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR‐BMOD trial TA Wadden, JP Foreyt, GD Foster, JO Hill, S Klein, PM O'neil, MG Perri, ... Obesity 19 (1), 110-120, 2011 | 588 | 2011 |